Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
Ann Intern Med
.
2022 Feb;175(2):W14.
doi: 10.7326/L21-0731.
Authors
Faizan Khan
1
,
Tobias Tritschler
2
,
Gregoire Le Gal
3
,
Dean A Fergusson
4
,
Marc A Rodger
5
Affiliations
1
University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
2
Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
3
Ottawa Hospital Research Institute, University of Ottawa, and The Ottawa Hospital, Ottawa, Ontario, Canada.
4
University of Ottawa, Ottawa Hospital Research Institute, and The Ottawa Hospital, Ottawa, Ontario, Canada.
5
Ottawa Hospital Research Institute, Ottawa, Ontario, and McGill University, Montreal, Quebec, Canada.
PMID:
35157815
DOI:
10.7326/L21-0731
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / adverse effects
Hemorrhage / chemically induced
Humans
Venous Thromboembolism* / drug therapy
Substances
Anticoagulants